Dynamic Assessment of Local Abdominal Tissue Concentrations of Cisplatin During a HIPEC Procedure: Insights from a Porcine Model
Open Access
- 12 February 2025
- journal article
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 32 (5) , 3804-3813
Abstract
Background: This study aimed to establish a feasible large porcine model for dynamic assessment of cisplatin concentrations in carcinomatosis-relevant abdominal tissues using microdialysis during and after HIPEC combined with cytoreductive surgery. Methods: In total, eight pigs underwent open abdominal cytoreductive surgery followed by HIPEC. Microdialysis was employed for dynamic cisplatin concentration sampling in abdominal organs and tissue. Cisplatin dialysate concentrations were analyzed using the UPLC-MS/MS method. STATA (version 18.0) was used to perform a two-compartment model with a zero-order distribution to analyze pharmacokinetic parameters. Results: Detectable cisplatin concentrations in the evaluated target tissues persisted for at least 6 h post-HIPEC. Higher concentrations were found in superficial tissues; however, the difference was not statistically significant. The cisplatin concentrations were comparable for the stomach, rectum, and liver but higher in the peritoneal lining of the abdominal wall, with the lowest median average peak concentration (C max) in the rectum (0.50 µg/mL) and the highest median C max in the peritoneum (2.80 µg/mL). No statistically significant differences in cisplatin area under the curve from time zero to the time of the last sample collection (AUC0–last) were found between any of the abdominal compartments except the peritoneal lining of the abdominal wall, which was significantly higher compared with most of the other abdominal tissues {smallest difference; peritoneum 1/liver 2; 1.96 [95% confidence interval (CI) 0.90; 4.26, P = 0.09] and largest difference; peritoneum 3/rectum profound; 4.60 [95% CI 1.94; 10.90, P = 0.001]}. Conclusions: Our investigation revealed comparable cisplatin concentrations across abdominal organ surfaces, except higher concentrations in the peritoneal lining of the abdominal wall than in the stomach, rectum, and liver. This model holds promise for future research into HIPEC interventions and anticancer effectiveness.Keywords
Funding Information
- Søster og Verner Lipperts Fond
- Kræftens Bekæmpelse (R302-A17420)
- Riisfort Fonden
- Knud og Edith Eriksens Mindefond
- Fabrikant Einar Willumsens Mindelegat (J. nr. 500028)
- Andersen-Isted fond
- Fonden til Lægevidenskabens Fremme (L-2022-00060)
- Inge og Asker Larsens Fond (039252-0005 seb/ruh)
- Frimodt-Heinike Fonden
- Familien Hede Nielsens Fond
- Agnethe Løvgreens Fond
- Aarhus Universitet
This publication has 29 references indexed in Scilit:
- Swine as Models in Biomedical Research and Toxicology TestingVeterinary Pathology, 2011
- Improving Bioscience Research Reporting: The ARRIVE Guidelines for Reporting Animal ResearchPLOS Biology, 2010
- Extracellular fluid concentrations of cisplatin, carboplatin, and oxaliplatin in brain, muscle, and blood measured using microdialysis in nonhuman primatesCancer Chemotherapy and Pharmacology, 2009
- Current status and future strategies of cytoreductive surgery plus intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosisWorld Journal of Gastroenterology, 2008
- Peritoneal Carcinomatosis of Colorectal OriginAnnals of Surgery, 2006
- Pharmacokinetics and pharmacodynamics of cisplatin after intraoperative hyperthermic intraperitoneal chemoperfusion (HIPEC).2003
- Cancer-Targeted Polymeric DrugsCurrent Cancer Drug Targets, 2002
- Use of microdialysis to study platinum anticancer agent pharmacokinetics in preclinical modelsJournal of Experimental Therapeutics and Oncology, 2002
- Methodological issues in microdialysis sampling for pharmacokinetic studiesAdvanced Drug Delivery Reviews, 2000
- Body Surface Area of Female SwineJournal of Animal Science, 1973